Forte Biosciences, Inc. (FBRX)

76.96 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 14:14
More

Forte Biosciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for FBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
July 27, 2026 --
July 09, 2026 --
May 13, 2026 --
May 11, 2026 --
April 06, 2026 --
April 02, 2026 --
April 01, 2026 --
March 31, 2026 --
February 20, 2026 --
February 11, 2026 --
January 19, 2026 --
November 14, 2025 --
August 18, 2025 --
Date Value
August 15, 2025 --
June 30, 2025 --
June 24, 2025 --
June 05, 2025 --
May 16, 2025 --
April 01, 2025 --
February 21, 2025 --
January 21, 2025 --
September 03, 2024 --
August 19, 2024 --
August 15, 2024 --
May 14, 2024 --
April 08, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
argenx SE Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade